河北医科大学第二医院
纸质出版:2018
移动端阅览
[1]崔娜,姜蕾,杨爱敏,张杰,许月明,王玮,郝桂敏.坤泰胶囊治疗卵巢储备功能低下不孕症患者33例临床观察[J].中医杂志,2018,59(02):132-136.
CUI Na, JIANG Lei, YANG Aimin, et al. Clinical Observation of Kuntai Jiaonang(坤泰胶囊) in Treating 33 Patients with Hypofunction of Ovarian Reserve Infertility[J]. Journal of Traditional Chinese Medicine2018, 59(2): 132-136.
[1]崔娜,姜蕾,杨爱敏,张杰,许月明,王玮,郝桂敏.坤泰胶囊治疗卵巢储备功能低下不孕症患者33例临床观察[J].中医杂志,2018,59(02):132-136. DOI: 10.13288/j.11-2166/r.2018.02.011.
CUI Na, JIANG Lei, YANG Aimin, et al. Clinical Observation of Kuntai Jiaonang(坤泰胶囊) in Treating 33 Patients with Hypofunction of Ovarian Reserve Infertility[J]. Journal of Traditional Chinese Medicine2018, 59(2): 132-136. DOI: 10.13288/j.11-2166/r.2018.02.011.
目的探讨坤泰胶囊治疗卵巢储备功能低下不孕症患者的临床疗效和安全性。方法将卵巢储备功能低下不孕症患者68例随机分为治疗组33例及对照组35例。治疗组给予坤泰胶囊口服
每日3次
每次2.0 g;对照组给予脱氢表雄酮口服
每日3次
每次25 mg。两组疗程均为3个月经周期。治疗期间观察患者的用药情况、不良反应、妊娠情况。治疗结束后随访4个体外受精-胚胎移植周期。比较两组患者治疗前后血清基础卵泡刺激素(FSH)、基础雌二醇(E2)、促黄体生成素(LH)、卵泡期抗苗勒激素(AMH)水平、基础窦卵泡数(AFC)
随访期间的体外受精-胚胎移植临床妊娠率及周期临床妊娠率。结果两组患者治疗前后比较
FSH、E2、LH及AFC差异均无统计学意义(P>0.05)。治疗组5例未行体外受精-胚胎移植
治疗组临床妊娠5例
对照组9例。第1周期治疗组临床妊娠3例(17例移植患者
下同)
对照组1例(21例);第2周期治疗组临床妊娠1例(9例)
对照组2例(20例);第3周期治疗组临床妊娠1例(2例)
对照组4例(6例);第4周期治疗组无移植患者
对照组临床妊娠2例(2例)。研究过程对照组部分患者出现面部痤疮
治疗组未发现不良事件。结论坤泰胶囊对卵巢储备功能低下不孕症患者的卵巢储备功能的改善效果及临床妊娠率与脱氢表雄酮相当
且安全性好。
Objective To explore the clinical effect and safety of Kuntai Jiaonang(坤泰胶囊) in treating patients with hypofunction of ovarian reserve infertility. Methods Sixty-eight patients with hypofunction of ovarian reserve infertility were randomized into a treatment group( 33 cases) and a control group( 35 cases). The treatment group was given oral Kuntai Jiaonang
2. 0 g each time
3 times each day. The control group was given oral dehydroepiandrosterone
25 mg each time
3 times each day. The course in both groups was 3 menstrual cycles. During treatment
patients’ medication
side effect and pregnancy were examined. At the end of treatment
follow-up was carried out for 4 cycles of in vitro fertilization and embryo transfer. Patients’ serum levels of basal follicle stimulate hormone( FSH)
basal estradiol( E2)
luteinizing hormone( LH) and follicular stage anti-Mullerian hormone( AMH)
as well as basal antral follicle number( AFC)
clinical pregnancy rate of in vitro fertilization and embryo transfer during follow-up and periodic clinical pregnancy rate were compared between two groups before and after treatment.Results Compared between patients in two groups before and after treatment
there were no significant differences in levels of FSH
E2
LH and AFC( P > 0. 05). In the treatment group
5 patients did not go through in vitro fertilization and embryo transfer. The clinical pregnancy was 5 cases in the treatment group
and 9 cases in the control group.In the first cycle
the clinical pregnancy was 3 of 17 cases in the treatment group
and 1 of 21 cases in the control group. In the second cycle
the clinical pregnancy was 1 of 9 cases in the treatment group
and 2 of 20 cases in the control group. In the third cycle
one of two patients in the treatment group
and 4 of 6 patients in the control group were pregnant. In the forth cycle
there was no transfer patient in the treatment group
and the pregnancy in the control group was 2 of 2 cases. During the research
some patients in the control group had facial acne. No side effect was found in the treatment group. Conclusion The improvement of ovarian reserve function and clinical pregnancy rate in patients with hypofunction of ovarian reserve infertility by Kuntai Jiaonang was equivalent to that by dehydroepiandrosterone. Moreover
Kuntai Jiaonang seems to be safe.
0
浏览量
444
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号